CEO of Bionit Inc., Chanbong Kim, participated in the Vietnam Medical Device Seminar and Exhibition held in Da Nang, Vietnam from May 27 to 28, 2022. In particular, on the 28th, CEO Chan-bong Kim presented the seminar under the title “The effect of cancer screening program and new liquid-based cytology system using automated centrifugation technology”. Through the presentation, the current situation of cervical cancer in Vietnam was reviewed, and the importance of the national screening program was announced to reduce the incidence of cervical cancer. In addition, by introducing the WellPrep Liquid-based Cytology system developed by Bionit Inc., it received great attention from the Vietnamese Ministry of Health and Welfare officials and Vietnamese medical device distribution companies. After the event, Bionit Inc. is said to have signed a contract with a parent company for the exclusive goodwill of the WellPrep system in Vietnam.